Oppenheimer & Co’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-10,717
| Closed | -$62K | – | 1424 |
|
|
2020
Q3 | $62K | Sell |
10,717
-3,583
| -25% | -$20.7K | ﹤0.01% | 1252 |
|
|
2020
Q2 | $97K | Sell |
14,300
-9,535
| -40% | -$64.7K | ﹤0.01% | 1207 |
|
|
2020
Q1 | $152K | Sell |
23,835
-20
| -0.1% | -$128 | ﹤0.01% | 1073 |
|
|
2019
Q4 | $249K | Sell |
23,855
-685
| -3% | -$7.15K | 0.01% | 1095 |
|
|
2019
Q3 | $96K | Sell |
24,540
-5,415
| -18% | -$21.2K | ﹤0.01% | 1216 |
|
|
2019
Q2 | $445K | Buy |
29,955
+1,782
| +6% | +$26.5K | 0.01% | 860 |
|
|
2019
Q1 | $699K | Buy |
28,173
+11,521
| +69% | +$286K | 0.02% | 697 |
|
|
2018
Q4 | $299K | Buy |
+16,652
| New | +$299K | 0.01% | 942 |
|
|
2015
Q4 | – | Sell |
-3,001
| Closed | -$276K | – | 1392 |
|
|
2015
Q3 | $276K | Sell |
3,001
-1,098
| -27% | -$101K | 0.01% | 1022 |
|
|
2015
Q2 | $360K | Buy |
4,099
+1,098
| +37% | +$96.4K | 0.01% | 1023 |
|
|
2015
Q1 | $223K | Buy |
+3,001
| New | +$223K | 0.01% | 1245 |
|